Skip to main content
. 2021 Aug 10;478(15):2977–2997. doi: 10.1042/BCJ20210284

Figure 4. SBI-0206965 inhibits AICAR and uridine uptake in C2C12 myotubes.

Figure 4.

(A,B) C2C12 myotubes or isolated mouse skeletal muscle (extensor digitorum longus) were pre-incubated for 30 min with vehicle (0.1% DMSO) or the indicated concentrations of SBI-0206965 followed by an additional 1-h incubation without (vehicle) or with AICAR (1 mM). Cell or tissue extracts were subjected to ZMP analysis by liquid chromatography-mass spectrometry. (C) C2C12 myotubes were incubated in the absence (vehicle) or presence of the indicated compounds for 30 min followed by an addition of [3H]-uridine for 1 min for determination of uridine uptake. Results are expressed as mean ± SEM. *P < 0.05 (AICAR (A,B) or vehicle (C) vs. SBI-0206965 or NBMPR). N.D.; not detectable.